4Reyes BA, Beutner KR, Cullen SI, et al. Butenafine, a fungicidal benzylamine derivative, used once daily for the treatment of interdigital tinea pedis. Int J Dermatol, 1998, 37:450-453
5Greer DL, Weiss J, Rodriguez DA, et al. A randomized trial to assess once-daily topical treatment of tinea corporis with butenafine,a new antifungal agent. J Am Acad Dermatol, 1997, 37(2 Pt 1):231-235.
6Lesher JL Jr, Babel DE, Stewart DM, et al. Butenafine 1% cream in the treatment of tinea cruris: a multicenter, vehicle-controlled,double-blind trial. J Am Acad Dermatol, 1997, 36(2 Pt 1 ):S20-S24.
7Savin R, De Villez RL, Elewski B, et al. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial. J Am Acad Dermatol,1997, 36(2 Pt 1) :S15-S19.
8Tschen E, Elewski B, Gorsulowsky DC, et al. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream. J Am Acad Dermatol, 1997, 36(2 Pt 1 ):S9-14.
9Odom RB. Update on topical therapy for superficial fungal infections: focus on butenafine. J Am Acad Dermatol, 1997, 36 (2 Pt1 ): S1-S2.
10Tanuma H, Doi M, Ohta Y, et al. Butenafine hydrochloride (Mentax) cream for the treatment of hyperkeratotic type tinea pedis and its transfer into the horny layer, with or without concomitant application of 20% urea ointment (Keratinamin). Mycoses, 2001, 44:287-299.
